Skip to main content

Tweets

#1456 💥In a real-world UK PsA cohort, 25% had joint erosion @ diagnosis ➡️Mean disease duration 34mo. @ diagnosis ➡️Mean disability score = mod. to severe 💥Delay in diagnosis=poor outcomes ‼️Are we doing enough to catch PsA early? ? 🔑Earlier detection key #ACR @RheumNow

Caoilfhionn Connolly @CaoilfhionnMD ( View Tweet )

1 year 2 months ago
#1375🏋️‍♀️ Strength Training in RA ➡️ 12-week trial 28 ♀️ High-intensity(HIRT) v. Low-intensity+blood flow restriction(LIT-BFR) 🔴Equivalent gains:Lat-pulldown, biceps curl 🔴Knee extension:HIRT>LIT-BFR (non-significant) ✅ LIT-BFR: Alternative for RA sarcopenia #ACR24 @RheumNow

Caoilfhionn Connolly @CaoilfhionnMD ( View Tweet )

1 year 2 months ago
John Stone Steroid-free AAV CYCLOPS: steroid tox like “wallpaper on room” WGET (ETN for GCA) - taper off by 6 mos - neg trial but started tapers RAVE - low doses 8-9 mg/d over 18 mos LoVAS - low dose steroid equally eff ADVOCATE - AVA one month taper, tox score #ACR24 @RheumNow https://t.co/C7eLK5UNPM
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
It's always so dispiriting to see PMR patients rack up steroid side effects in front of your eyes. (the intense motivation to do better than pred for our PMR patients) #ACR24 @SattuiSEMD @RADoctor ABST0975 @RheumNow https://t.co/FTsvrTIt2F
David Liew @drdavidliew ( View Tweet )
1 year 2 months ago
#1474 🔬Severe PsA? Guselkumab (GUS) has promise! ➡️In bionaive pts with severe disease activity, GUS v. PBO resulted in: 🔴73% improvement in joints 🔴53% lower disease activity 🔴63% better PtGA by 2 years ➡️Rapid results by W2, sustained through W100. #ACR @RheumNow

Caoilfhionn Connolly @CaoilfhionnMD ( View Tweet )

1 year 2 months ago
Is participation in RISE assoc with improved quality of care? ➡️Enrolment assoc w ⬆️performance in several quality measures ➡️Most marked in practices with lower baseline performance ⏩Registry participation has potential to improve quality of rheum care Ab1644 #ACR24 @RheumNow

Mrinalini Dey @DrMiniDey ( View Tweet )

1 year 2 months ago
Biosimilar changes ASP outpacing reimbursement making not affordable to use Working with CMS but needs further legislation to fix this FDA may change interchangeability status for medications to no longer require switching studies @ACRheumDC @RheumNow #ACR24 https://t.co/daYQJvsHRG
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
What’s on tap for Trump health care agenda? Uncertainty as to what priorities and actions will be ACR has plans to address legislative, regulatory, and state affairs @ACRheumDC #ACR24 @RheumNow https://t.co/a5z4RIOjRC
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
A meta-analysis of 11 randomized trials shows no significant difference in efficacy of bDMARDs for early vs. established axial spondyloarthritis (axSpA). Treating at different stages yields comparable short-term outcomes. Abstr#1468 #Spondyloarthritis #RheumatologyResearch… https://t.co/QYuTcVj2m1 https://t.co/ADzEEbCvUM
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
@ACRheumDC State Update: No changes at executive level Some shifts in state legislation With political changes and new administration, states will probably take larger role in healthcare legislation - PBM reform, copay accum, prior auth/step, reprod healthcare @RheumNow #ACR24 https://t.co/jc77HCLxqQ
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
State Update @ACRheumDC No executive level changes, some state legislative flips Political changes will likely lead to more state legislative healthcare legislation - In the works for PBM reform, copay accum, prior auth/Step, reprod healthcare @RheumNow #ACR24 https://t.co/94KyHU0Blr
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
#1326 🔬 Predicting Imminent Inflammatory Arthritis ➡️543 anti-CCP+ at-risk (high/low) tracked 🔑Predictors for IA in high-risk: 🔴EMS≥30min(OR 11) 🔴RF+(OR 6) 🔴US PD(OR 5) 🔴smJTC (OR 5) 🔑Predictors for IA in low risk: 🔴RF+(OR 8) 🔴Anti CCP >3xULN(OR 7) #ACR24 @RheumNow https://t.co/ou9HNcNb8X
Caoilfhionn Connolly @CaoilfhionnMD ( View Tweet )
1 year 2 months ago
×